Your browser doesn't support javascript.
loading
NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis.
Hu, Haifeng; Li, Borui; Chen, Haidi; Fan, Guixiogn; Ye, Zeng; Ji, Shunrong; Yu, Xianjun; Xu, Xiaowu; Qin, Yi.
Afiliación
  • Hu H; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Chen H; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Fan G; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Ye Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Ji S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yu X; Shanghai Pancreatic Cancer Institute, Shanghai, China.
  • Xu X; Pancreatic Cancer Institute, Fudan University, Shanghai, China.
  • Qin Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Mol Carcinog ; 63(2): 195-208, 2024 Feb.
Article en En | MEDLINE | ID: mdl-37846815
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Límite: Animals / Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Límite: Animals / Humans Idioma: En Revista: Mol Carcinog Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: China